key: cord-0984808-sjzjyn1t authors: Azab, Mohammed A; Azzam, Ahmed Y title: referenImpact of COVID-19 pandemic on the management of glioma patients around the world. An evidence-based review date: 2021-05-09 journal: Brain Disord DOI: 10.1016/j.dscb.2021.100012 sha: 5326b8bcfbad1b7ac9c0640146f7b1c77a5e9281 doc_id: 984808 cord_uid: sjzjyn1t BACKGROUND: The coronavirus pandemic has affected many health care services worldwide since the emergence of the first case in Wuhan. Surgical neuro-oncology care is a fundamental part of hospital services, making it susceptible to strategic changes amid the COVID-19 pandemic. METHODS: An electronic search on several databases (PubMed/Medline, Scopus, and Google Scholar) from the beginning of the pandemic to the end of 2020, each paper was reviewed independently. The publication inclusion and exclusion criteria were done using Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA) guidelines. RESULTS: Eight studies were found to be eligible for our meta-analysis. Most of the studies were on a retrospective basis, except one which was retrospective and prospective. An overall of 951 glioma patients’ were included for surgical admission from the beginning of the pandemic until 2020. Seventy-four patients' had mortality outcomes, and 250 patients had complications for both surgical admitted and non-surgical admitted purposes. CONCLUSIONS: To our knowledge, we made the first systematic review and meta-analysis regarding the management of glioma patients’ during the pandemic of COVID-19. Our main findings are that the number of surgical admissions for glioma patients’ did not significantly differ between COVID-19 negative and COVD-19 positive cases; however, surprisingly, we found that both overall complications and mortality outcomes were more significant COVID-19 negative patients’ from the reported studies. The coronavirus pandemic has affected many health care services worldwide since the emergence of the first case in Wuhan. Surgical neuro-oncology care is a fundamental part of hospital services, making it susceptible to strategic changes amid the COVID-19 pandemic. Surgical neuro-oncology is an intensive care unit (ICU) bed-consuming specialty that creates a dilemma in continuing surgical care delivery amid the pandemic. Facing an exhausting pandemic redirected different ICU facilities such as ventilators, personal protective equipment, and medical staff to COVID-19 cases, which subsequently disrupted offering surgical neuro-oncology services. Instability regarding offering a proper health care service for critical cancer patients was somewhat observed amid the pandemic. Moreover, patients with glioblastoma are fragile to face their health status and COVID-19 infection. A suggested reason for that is the relative immunocompromise of those patients from previous radiation and chemotherapy [1] . The postoperative mortality rate is higher in patients with cancer than those with benign diseases, as supported by a specific cohort study [2] . Several times, surgery cannot be postponed either due to the tumor's size or the rapid progression of cerebral edema. Considering the long-term effects of that pandemic, prompt policies should be assigned to prevent the deleterious outcome of postponing glioblastoma (GBM) surgeries. The benefit of indulging in urgent surgery to resect GBM should be balanced with the risk of exposing the patient and the staff to COVID-19 infection, which is a problematic issue. It was advised by the American college of surgeons to postpone any elective cancer surgery amid the COVID-19 pandemic. [3] . Neurosurgical associations published their guidelines for the management of malignant brain tumors amid the pandemic [4] . Each center in different countries of the world has reacted to the pandemic governed by the pandemic's effect on each country; therefore, the guidelines applied were modified accordingly. To date, there is no meta-analysis has been published investigating how COVID-19 affected the rate of surgical admissions in glioma patients and the occurrence of complications or associated mortality among different centers that published their experience. In this study, we aim to perform a meta-analysis of the available published data concerning the management of glioma patients in the published literature from the beginning of the pandemic to the end of 2020 concerning the number of operated surgeries, postoperative complications, and mortality outcomes. An electronic search on several databases (PubMed/Medline, Scopus and Google Scholar) was done by two authors (AYA, MAA) using the keywords ("Glioma AND COVID-19", "Glioma AND SARS-CoV-2", "Glioblastoma AND COVID-19", "Glioblastoma AND SARS-CoV-2", "Oligodendroglioma AND COVID-19", "Oligodendroglioma AND SARS-CoV-2", "Astrocytoma AND COVID-19", "Astrocytoma AND SARS-CoV-2", "Ependymoma AND COVID-19", "Neurosurgical practice AND COVID-19", "Neurosurgical practice AND SARS-CoV-2", "Neurosurgery AND COVID-19" and "Neurosurgery AND SARS-CoV-2") from the beginning of the pandemic to the end of 2020 each paper was reviewed on an independent basis. Conflicts between the authors have been solved by the re-screening method. The publication inclusion and exclusion criteria were done using Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA) guidelines. A total number of 1412 articles were identified on the databases searching phase and listed on PRISMA chart diagram Figure 1 , 984 articles were eligible for abstract screening to determine whether the article is eligible for the analysis or not. The full-text screening phase included 295 articles by two authors (AYA, MAA) on an independent basis to check the included details about the management of glioma patients' during the pandemic of COVID-19 during 2020. Data from 51 articles were used for qualitative synthesis (systematic review). Data from 8 articles were extracted into two groups for the quantitative synthesis (meta-analysis), COVID-19 negative and COVID-19 positive glioma cases. The analysis was done dichotomously according to the number of surgical admissions, complications, and mortality outcomes between the two groups. Quantitative synthesis (meta-analysis) was made using Review Manager V5.4.1 by (AYA) and revised by (MAA). The analysis results were pooled among the studies, and the results were weighted at the 95% CI data sensitivity can vary. The inconsistency I 2 test was also measured. The sampling error within a sample is a part of the variance (or error) due to differences between studies rather than solely due to sampling error. It is common for heterogeneity to be high when I 2 is greater than 75% and when I 2 is less than 25%. If we had no significant statistical variance, we would get a fixed-effect model. We made a modified assessment methodology concerning the studies involved in the quantitative synthesis to ensure the quality and availability of each study's data separately, and the assessment methodology maximum score is 4 (1= poor, 2= fair, 3= good, 4= well) Table 1 . Cochrane risk of bias assessment tool was used to estimate each study's bias on an independent basis. The results were primarily moderate quality studies included in the analysis, according to the risk of bias assessment tool Figure 2, Figure 3 . We also used the funnel plot for publications bias estimation on 95% CI. The result was an asymmetrical shape; however, the number of the included studies is less than ten Eight studies were found to be eligible for our meta-analysis. Most of the studies were on a retrospective basis, except one which was retrospective and prospective. An overall of 951 glioma patients' was included for surgical admission from the beginning of the pandemic until 2020. Seventy-four patients' had mortality outcomes, and 250 patients had complications for both surgical admitted, and non-surgical (overall) admitted purposes Table 1 . Based on the published data from different countries, an overall number of 5469 neurosurgical admitted cases were reported in the literature in the period of our analysis eligibility; however, not all of them were glioma cases. We made a separate analysis to discriminate and assess the glioma cases separately. By analysis, we did not notice a We also tried to compare the mortality outcome between COVID-19 positive and COVID-19 negative glioma patients through different centers. Interestingly, we noticed that COVID-19 negative glioma patients had more mortality than infected patients (OR= We also found that the complications were more noticed in COVID-19 negative patients We have taken a comprehensive view back at different experiences involved in managing glioma patients' during the pandemic in a time interval from the beginning of the pandemic to the end of 2020; all centers shared the same concept operating on emergent glioma cases. Strict safety precaution measures were adopted in all centers that were reviewed in this review. We took a simple look at the different strategies implemented at those centers regarding admission, inpatient, and discharge policies Table 2 . Since The global neurosurgical community can benefit from this meta-analysis results by considering the management's experience, which has been done in published literature what we can learn from this that we should care all admitted glioma cases without giving more beneficial services to a specific group than others, including prevention of discrimination for care between COVID-19 positive and COVID-19 negative cases. We reviewed the current guidelines for glioma patients' from the published literature and summarized them in How we treat patients with brain tumour during the COVID-19 pandemic. ESMO Open COVID-19) and Neurosurgery: Literature and Neurosurgical Societies Recommendations Update Early Responses of Neurosurgical Practice to the Coronavirus Disease 2019 (COVID-19) Pandemic: A Rapid Review Neurosurgical Practice During the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Pandemic: A Worldwide Survey Lessons from the present: Intraoperative neurophysiological monitoring organization during the COVID-19 pandemic in Lombardy, northern Italy Letter to the Editor Regarding "Battle-Tested Guidelines and Operational Protocols for Neurosurgical Practice in Times of a Pandemic: Lessons Learned from COVID-19 Natura non facit saltus: a phase 2 proposal to manage brain tumors cases from the Neuro-oncology section of the Italian Society of Neurosurgery (SINch®) An Australian Response to the COVID-19 Pandemic and Its Implications on the Practice of Neurosurgery just before and during the Covid-19 pandemic Even with COVID-19 neurosurgeons should still perform necessary urgent/emergent neurosurgery to avoid major permanent neurological deficits Preliminary Recommendations for Surgical Practice of Neurosurgery Department in the Central Epidemic Area of 2019 Coronavirus Infection Lessons from China When Performing Neurosurgical Procedures During the Coronavirus Disease 2019 (COVID-19) Pandemic. World Neurosurg Experiences of practicing surgical neuro-oncology during the COVID-19 pandemic Patients with Coronavirus 2019 (COVID-19) and Surgery: Guidelines and Checklist Proposal How SARS-CoV-2 is forcing us to reconsider and reorganize our daily neurosurgical practice Investigating the real impact of COVID-19 pandemic on the daily neurosurgical practice? Neurochirurgie Modification of neurosurgical practice during corona pandemic: Our experience at AIIMS patna and long term guidelines Neurosurgery and Neurology Practices during the Novel COVID-19 Pandemic: A Consensus Statement from India Neurosurgery training in India during the COVID-19 pandemic: straight from the horse's mouth. Neurosurg Focus Preparedness and guidelines for neurosurgery in the COVID-19 era: Indian perspective from a tertiary care referral hospital Adapting Neurosurgery Practice During the COVID-19 Pandemic in the Indian Subcontinent Impact of the COVID-19 Pandemic on Neurosurgical Practice in India: Results of an Anonymized National Survey Management of Neurosurgical Cases in a Tertiary Care Referral Hospital During the COVID-19 Pandemic: Lessons from a Middle-Income Country Saudi neurosurgery residency and COVID-19: How are we coping? Neurosciences (Riyadh) Consensus Statement of the Saudi Association of Neurological Surgery (SANS) on Triage of Neurosurgery Patients During COVID-19 Pandemic in Saudi Arabia Perception of Neurosurgery Residents and Attendings on Online Webinars During COVID-19 Pandemic and Implications on Future Education Safety measures for COVID-19: a review of surgical preparedness at four major medical centres in Saudi Arabia The Saudi Spine Society guidelines on spinal surgery during the COVID-19 pandemic The longitudinal impact of COVID-19 pandemic on neurosurgical practice Protected Stroke Mechanical Thrombectomy Code During the Coronavirus (COVID-19) Pandemic: Southwestern Part of Saudi Arabia Stroke Unit Local Protocol. Cureus Strategies to Offer Uninterrupted Neurosurgical Care at a Tertiary Center in Makka amid COVID-19 Pandemic Coronavirus disease 2019 (COVID-19) in neurology and neurosurgery: A scoping review of the early literature COVID-19: Launching Neurosurgery into the Era of Telehealth in the United States COVID-19) and Neurosurgery Residency Action Plan: An Institutional Experience from the United States Sheltered Neurosurgery During COVID-19: The Emory Experience Mechanical Thrombectomy in the Era of the COVID-19 Pandemic: Emergency Preparedness for Neuroscience Teams: A Guidance Statement From the Society of Vascular and Interventional Neurology Neurosurgical management of brain and spine tumors in the COVID-19 era: an institutional experience from the epicenter of the pandemic SARS-CoV-2 associated viral encephalitis with mortality outcome Early Effects of COVID-19 Pandemic on Neurosurgical Training in the United States: A Case Volume Analysis of 8 Programs Coronavirus Neurosurgical/Head and Neck Drape to Prevent Aerosolization of Coronavirus Disease 2019 (COVID-19): The Lenox Hill Hospital/Northwell Health Solution Early Changes to Neurosurgery Resident Training During the COVID-19 Pandemic at a Large U Challenges of Neurosurgery Education During the Coronavirus Disease 2019 (COVID-19) Pandemic: A U Case Volumes and Perioperative Coronavirus Disease 2019 Incidence in Neurosurgical Patients During a Pandemic: Experiences at Two Tertiary Care Centers in Washington Neuro-oncology practice guidelines from a high-volume surgeon at the COVID-19 epicenter giving priority to elderly patients.